Načítá se...
Lipid lowering and Alzheimer disease risk: A mendelian randomization study
OBJECTIVE: To examine whether genetic variation affecting the expression or function of lipid‐lowering drug targets is associated with Alzheimer disease (AD) risk, to evaluate the potential impact of long‐term exposure to corresponding therapeutics. METHODS: We conducted Mendelian randomization anal...
Uloženo v:
| Vydáno v: | Ann Neurol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Inc.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6944510/ https://ncbi.nlm.nih.gov/pubmed/31714636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25642 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|